Literature DB >> 9173902

Identification of amino acid residues responsible for differences in substrate specificity and inhibitor sensitivity between two human liver dihydrodiol dehydrogenase isoenzymes by site-directed mutagenesis.

K Matsuura1, Y Deyashiki, K Sato, N Ishida, G Miwa, A Hara.   

Abstract

Human liver dihydrodiol dehydrogenase isoenzymes (DD1 and DD2), in which only seven amino acid residues are substituted, differ remarkably in specificity for steroidal substrates and inhibitor sensitivity: DD1 shows 20alpha-hydroxysteroid dehydrogenase activity and sensitivity to 1,10-phenanthroline, whereas DD2 oxidizes 3alpha-hydroxysteroids and is highly inhibited by bile acids. In the present study we performed site-directed mutagenesis of the seven residues (Thr-38, Arg-47, Leu-54, Cys-87, Val-151, Arg-170 and Gln-172) of DD1 to the corresponding residues (Val, His, Val, Ser, Met, His and Leu respectively) of DD2. Of the seven mutations, only the replacement of Leu-54 with Val produced an enzyme that had almost the same properties as DD2. No significant changes were observed in the other mutant enzymes. An additional site-directed mutagenesis of Tyr-55 of DD1 to Phe yielded an inactive protein, suggesting the catalytically important role of this residue. Thus a residue at a position before the catalytic Tyr residue might play a key role in determining the orientation of the substrates and inhibitors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9173902      PMCID: PMC1218315          DOI: 10.1042/bj3230061

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Bacterial morphine dehydrogenase further defines a distinct superfamily of oxidoreductases with diverse functional activities.

Authors:  N C Bruce; D L Willey; A F Coulson; J Jeffery
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

5.  Structure of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP+.

Authors:  M J Bennett; B P Schlegel; J M Jez; T M Penning; M Lewis
Journal:  Biochemistry       Date:  1996-08-20       Impact factor: 3.162

6.  Three-dimensional structure of rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily.

Authors:  S S Hoog; J E Pawlowski; P M Alzari; T M Penning; M Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

7.  Reduction of prostaglandin D2 to 9 alpha,11 beta-prostaglandin F2 by a human liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isozyme.

Authors:  H Ohara; T Nakayama; Y Deyashiki; A Hara; Y Miyabe; F Tsukada
Journal:  Biochim Biophys Acta       Date:  1994-11-17

8.  3 alpha-hydroxysteroid dehydrogenase activity of the Y' bile acid binders in rat liver cytosol. Identification, kinetics, and physiologic significance.

Authors:  A Stolz; H Takikawa; Y Sugiyama; J Kuhlenkamp; N Kaplowitz
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

9.  Regulation of human dihydrodiol dehydrogenase by Michael acceptor xenobiotics.

Authors:  P J Ciaccio; A K Jaiswal; K D Tew
Journal:  J Biol Chem       Date:  1994-06-03       Impact factor: 5.157

10.  Mechanism of aldose reductase inhibition: binding of NADP+/NADPH and alrestatin-like inhibitors.

Authors:  T Ehrig; K M Bohren; F G Prendergast; K H Gabbay
Journal:  Biochemistry       Date:  1994-06-14       Impact factor: 3.162

View more
  7 in total

Review 1.  Structural and Functional Biology of Aldo-Keto Reductase Steroid-Transforming Enzymes.

Authors:  Trevor M Penning; Phumvadee Wangtrakuldee; Richard J Auchus
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

2.  Kinetic alteration of a human dihydrodiol/3alpha-hydroxysteroid dehydrogenase isoenzyme, AKR1C4, by replacement of histidine-216 with tyrosine or phenylalanine.

Authors:  T Ohta; S Ishikura; S Shintani; N Usami; A Hara
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

3.  Comparison of crystal structures of human type 3 3alpha-hydroxysteroid dehydrogenase reveals an "induced-fit" mechanism and a conserved basic motif involved in the binding of androgen.

Authors:  Jean-François Couture; Karine Pereira de Jésus-Tran; Anne-Marie Roy; Line Cantin; Pierre-Luc Côté; Pierre Legrand; Van Luu-The; Fernand Labrie; Rock Breton
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

Review 4.  Promiscuity and diversity in 3-ketosteroid reductases.

Authors:  Trevor M Penning; Mo Chen; Yi Jin
Journal:  J Steroid Biochem Mol Biol       Date:  2014-12-10       Impact factor: 4.292

5.  Sequence of the cDNA of a human dihydrodiol dehydrogenase isoform (AKR1C2) and tissue distribution of its mRNA.

Authors:  H Shiraishi; S Ishikura; K Matsuura; Y Deyashiki; M Ninomiya; S Sakai; A Hara
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

6.  Roles of the C-terminal domains of human dihydrodiol dehydrogenase isoforms in the binding of substrates and modulators: probing with chimaeric enzymes.

Authors:  K Matsuura; A Hara; Y Deyashiki; H Iwasa; T Kume; S Ishikura; H Shiraishi; Y Katagiri
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

Review 7.  Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms.

Authors:  Trevor M Penning; Jason E Drury
Journal:  Arch Biochem Biophys       Date:  2007-05-11       Impact factor: 4.013

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.